Successful treatment of fetal hemolytic disease due to glucose phosphate isomerase deficiency (GPI) using repeated intrauterine transfusions: a case report
- PMID: 26509025
- PMCID: PMC4614658
- DOI: 10.1002/ccr3.358
Successful treatment of fetal hemolytic disease due to glucose phosphate isomerase deficiency (GPI) using repeated intrauterine transfusions: a case report
Abstract
Hemolytic anemia due to GPI deficiency can be severe and life threatening during fetal life. When parents decline invasive testing, ultrasound monitoring of fetuses at risk is feasible. Intrauterine transfusion can be effective for the treatment of severe fetal anemia due to GPI deficiency.
Keywords: Fetal anemia; GPI deficiency; intrauterine transfusion.
Figures
References
-
- Dallapiccola B, Novelli G, Ferranti G, Pachi A, Cristiani ML. Magnani M. First trimester monitoring of a pregnancy at risk for glucose phosphate isomerase deficiency. Prenat. Diagn. 1986;6:101–107. - PubMed
-
- Ravindranath Y, Paglia DE, Warrier I, Valentine W, Nakatani M. Brockway RA. Glucose phosphate isomerase deficiency as a cause of hydrops fetalis. N. Engl. J. Med. 1987;316:258–261. - PubMed
-
- Kanno H, Fujii H, Hirono A, Ishida Y, Ohga S, Fukumoto Y. Matsuzawa K, et al. Molecular analysis of glucose phosphate isomerase deficiency associated with hereditary hemolytic anemia. Blood. 1996;88:2321–2325. - PubMed
-
- Read J, Pearce J, Li X, Muirhead H, Chirgwin J. Davies C. The crystal structure of human phosphoglucose isomerase at 1.6 A resolution: implications for catalytic mechanism, cytokine activity and hemolytic anemia. J. Mol. Biol. 2001;309:447–463. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
